Alloferon-1 / Allokin alpha
8 indexed publications · 0 human studies · research from 2008 to 2022
Research goals studied
- Cancer & oncology
- Immune function
- Metabolic & glucose
Studies referencing Alloferon-1 / Allokin alpha
Alloferon Attenuates Acute Inflammation
2022 · Preclinical
Examined anti-inflammatory effects of Alloferon in vivo.
Alloferon Increases Chemosensitivity in Pancreatic Cancer Models
2022 · Preclinical
Studied Alloferon effects on chemotherapy sensitivity in pancreatic cancer models.
Central Nervous System Effects of Alloferon in Rats
2015 · Preclinical
Evaluated behavioral and CNS effects of Alloferon in rats.
Alloferon Enhances Natural Killer Cell Activity
2013 · Preclinical
Studied Alloferon effects on NK-cell activity and related immune responses.
Hybrid Alloferon-Containing Peptide with Antitumor Activity
2013 · Preclinical
Evaluated an Alloferon-containing hybrid peptide in tumor models.
Antitumor Activity of Alloferon
2012 · Preclinical
Evaluated antitumor activity of Alloferon in experimental models.
Comparative Biological Activity of Alloferon-1 and Allostatin-1
2011 · Preclinical
Compared biological activity of Alloferon-1 with the derivative Allostatin-1.
Alloferon Activates NF-kappaB Signaling
2008 · Preclinical
Examined NF-κB activation by Alloferon.
Working with Alloferon-1 / Allokin alpha?
Convert a vial to draw volume on the peptide calculator, or track protocols and vials in the free app.
Start tracking free